Skip to Content

Posts tagged with "Current Events"

  • Business and Markets

    Biogen Idec: What’s Going On?

    Biogen Idec has continued to fight off Carl Icahn, opposing his nominees to the company’s board and setting up a fight at the annual meeting later this year. But this morning (as a correspondent has just pointed out to me) the company’s stock has been taking off. It’s up about 7%, with the broad market… Read More
  • Current Events

    Sponsor A Gene?

    This has been forwarded on to me – if you find the idea of a gene sequence being sponsored by IKEA unusual, you should give the press release (and its associated links) a close look. . . Read More
  • Business and Markets

    Layoffs At Merck

    I’ve been hearing for a little while about impending layoffs at Merck. I decided, though, that this isn’t the environment to be putting up posts about rumors of job cuts – everyone’s jumpy enough already. But unfortunately, they aren’t rumors any more. What I’m hearing about, in person and via e-mail, is what sounds like… Read More
  • Current Events

    Greedy Biotechs?

    Smack in the middle of the biotech district of Cambridge, at one of the busy intersections, is a whopping billboard. It’s one of those that rotate vertical segments between three faces, and for some weeks now, all three of them have proclaimed loudly “Stop Biotech Greed!” Variations on the theme include how much money biotech… Read More
  • Current Events

    Wyeth v. Levine: Pre-emption Goes Away

    The idea of preemption in drug liability cases has been coming up a lot in recent years. If the FDA approves a drug, does that Federal-level approval stop liability suits at the state level, or not? The Supreme Court has ruled today in the Wyeth v. Levine case, which directly addresses this issue. And pre-emption… Read More
  • Current Events

    Ranbaxy in Trouble

    There are reports this morning that the FDA is halting further review of drug applications from one of the largest generic drug manufacturers, India’s Ranbaxy. It appears that some test results submitted to the agency have been found to be falsified. Update: here’s the FDA’s complaint (PDF). I’m not seeing any details on wha… Read More
  • Business and Markets

    Single, Simple Numbers: Use At Your Own Risk

    I wanted to link to this excellent article by Felix Salmon over at Wired. He’s talking about the mathematical formula that convinced many people on Wall Street that they’d figured out how to price out correlated risks in debt securities. As we all now know, they’d done no such thing, even though trillions of dollars… Read More
  • Autism

    Autism and Vaccines: Boiling Over Yet Again

    As you may well have heard by now, Ben Goldacre over at Bad Science has been involved in a wonderful altercation with both the anti-vaccination people there and with one of London’s big talk radio stations, LBC. And yes, this is happening just as Andrew Wakefield, one of the originators of the whole MMR vaccine… Read More
  • Current Events

    Their Crime? Collaborating With Other Scientists. . .

    Nature is rightfully drawing attention to the case of Arash and Kamiar Alaei, physicians (and brothers) from Iran, who have been sentenced to years in prison for supposedly “communicating with an enemy government”. Their real crime seems to have been attending international conferences, talking about HIV as a public health problem in Ir… Read More
  • Alzheimer's Disease

    Short Items: India, Sanjay Gupta, Satori Pharmaceuticals

    I have a few short links for everyone today. One series of posts that you might not have seen from Xconomy is a tour of the technological hot spots of India by Boston University’s Vinit Nijhawan. It’s interesting stuff for people like me who haven’t been to the country, and he isn’t shy about pointing… Read More
...91011...